Rigel Pharmaceuticals (RIGL) Gross Margin Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 526.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -5.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -165.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 21,616.00 |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn | 44.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.00 |
| Dec 31, 2025 | 152.00 |
| Sep 30, 2025 | 767.00 |
| Jun 30, 2025 | 319.00 |
| Mar 31, 2025 | -141.00 |
| Dec 31, 2024 | 54.00 |
| Sep 30, 2024 | -1,000.00 |
| Jun 30, 2024 | -362.00 |
| Mar 31, 2024 | -311.00 |
| Dec 31, 2023 | -992.00 |
| Sep 30, 2023 | -339.00 |
| Jun 30, 2023 | -52.00 |
| Mar 31, 2023 | -302.00 |
| Dec 31, 2022 | 172.00 |
| Sep 30, 2022 | -41.00 |
| Jun 30, 2022 | -298.00 |
| Mar 31, 2022 | -33.00 |
| Dec 31, 2021 | -65.00 |
| Sep 30, 2021 | 6.00 |
| Jun 30, 2021 | 125.00 |
| Mar 31, 2021 | -11.00 |
| Dec 31, 2020 | -58.00 |
| Sep 30, 2020 | 72.00 |
| Jun 30, 2020 | 125.00 |
| Mar 31, 2020 | 57.00 |
| Dec 31, 2019 | -66.00 |
| Sep 30, 2019 | -7.00 |
| Jun 30, 2019 | -131.00 |